Jeremy Green, Director, 10% Owner at FATE THERAPEUTICS INC (FATE), bought 1,880,864 shares at $1.68 ($3.2M) on 2024-12-20, disclosed to the SEC on 2024-12-26.
Open-market purchase of $3.2M FATE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.68 | 397,964 | $669K | 21.2% |
| 2 | $1.68 | 397,964 | $669K | 21.2% |
| 3 | $1.68 | 1,084,936 | $1.8M | 57.7% |
| Total | $1.68 avg | 1,880,864 | $3.2M | 100% |
| Filing → |
| STTK | SELL | 2024-12-06 | $333K | — | Filing → |
| ABSI | BUY | 2024-03-05 | $1000K | — | Filing → |
| AUGX | BUY | 2023-04-21 | $6.5M | — | Filing → |